Lynx1 Capital Management »

Bolt Biotherapeutics shares owned by Lynx1 Capital Management

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Lynx1 Capital Management from 13F filings

Historical chart of Lynx1 Capital Management investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Lynx1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Lynx1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $124k 31k 4.04

More positions owned by Lynx1 Capital Management

Stoke Therapeutics (STOK)
Gh Research Ordinary Shares (GHRS)
Cullinan Oncology (CGEM)
Agios Pharmaceuticals (AGIO)
Denali Therapeutics (DNLI)
C4 Therapeutics Com Stk (CCCC)
Korro Bio (KRRO)
Tscan Therapeutics (TCRX)
Xencor (XNCR)
Precision Biosciences Com New (DTIL)
Passage Bio Com New (PASG)
Neuphoria Therapeutics (NEUP)
Entrada Therapeutics (TRDA)
Cg Oncology (CGON)
Immatics SHS (IMTX)

View all positions for Lynx1 Capital Management

Top funds holding Bolt Biotherapeutics

Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Vivo Capital
Nan Fung Group Holdings
Renaissance Technologies
T3 Companies
Board of Trustees of The Leland Stanford Junior University
Pfizer
Lynx1 Capital Management
Geode Capital Management
Nano Cap New Millennium Growth Fund
Shay Capital
Vanguard Group
Citadel Advisors
BlackRock

View all funds holding Bolt Biotherapeutics